News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

24,758 Results

Type

Article (3585)
Company Profile (4)
Press Release (21169)

Section

Business (8652)
Career Advice (39)
Deals (1207)
Drug Delivery (19)
Drug Development (4324)
Employer Resources (12)
FDA (699)
Job Trends (1059)
News (14611)
Policy (1516)

Tag

Date

Last 7 days (19)
Last 30 days (99)
Last 365 days (1223)
2025 (158)
2024 (1237)
2023 (1319)
2022 (2976)
2021 (2787)
2020 (2293)
2019 (1546)
2018 (1196)
2017 (1348)
2016 (1159)
2015 (1327)
2014 (867)
2013 (725)
2012 (785)
2011 (880)
2010 (816)

Location

Africa (64)
Asia (1413)
Australia (377)
California (94)
Canada (52)
China (23)
Delaware (7)
Europe (4269)
Florida (19)
Japan (18)
Maryland (10)
Massachusetts (106)
New Jersey (103)
New York (50)
North Carolina (8)
Northern California (49)
Pennsylvania (7)
South America (61)
Southern California (30)
Texas (14)
Washington State (24)

Filters

Type

Article (3585)
Company Profile (4)
Press Release (21169)

Section

Business (8652)
Career Advice (39)
Deals (1207)
Drug Delivery (19)
Drug Development (4324)
Employer Resources (12)
FDA (699)
Job Trends (1059)
News (14611)
Policy (1516)

Tag

Date

Last 7 days (19)
Last 30 days (99)
Last 365 days (1223)
2025 (158)
2024 (1237)
2023 (1319)
2022 (2976)
2021 (2787)
2020 (2293)
2019 (1546)
2018 (1196)
2017 (1348)
2016 (1159)
2015 (1327)
2014 (867)
2013 (725)
2012 (785)
2011 (880)
2010 (816)

Location

Africa (64)
Asia (1413)
Australia (377)
California (94)
Canada (52)
China (23)
Delaware (7)
Europe (4269)
Florida (19)
Japan (18)
Maryland (10)
Massachusetts (106)
New Jersey (103)
New York (50)
North Carolina (8)
Northern California (49)
Pennsylvania (7)
South America (61)
Southern California (30)
Texas (14)
Washington State (24)

24,758 Results for "merck kgaa".

Sort By

Mergers & acquisitions

Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.

February 11, 2025
·
2 min read
·
Tristan Manalac
Drug Development

Merck KGaA Fails Phase III Study in Head and Neck Cancer, Scraps Trials

Merck KGaA’s drug candidate xevinapant in a late-stage trial was unable to significantly improve event-free survival in patients with locally advanced head and neck cancer.

June 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases

Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings

January 22, 2025
·
4 min read
Press Releases

Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer

January 9, 2025
·
5 min read
BioMidwest

Gamma Biosciences Announces Sale of Mirus Bio to Merck KGaA, Darmstadt, Germany, for $600 Million

Gamma Biosciences announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt, Germany, will acquire Gamma operating company Mirus Bio for $600 million in cash.

May 23, 2024
·
4 min read
Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

January 10, 2025
·
2 min read
Business

Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany

Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it has entered into a multi-target drug discovery collaboration with Merck KGaA, Darmstadt, Germany.

June 3, 2024
·
2 min read
Approvals

SpringWorks Wins FDA Nod for Neurofibromatosis Drug, Tees Up Challenge to AstraZeneca

The approval comes days after Germany’s Merck KGaA confirmed it was in advanced talks to acquire SpringWorks.

February 12, 2025
·
2 min read
·
Tristan Manalac
Drug Development

Merck KGaA, Darmstadt, Germany, Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemoradiotherapy (CRT) in patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

June 24, 2024
·
4 min read
Cancer

Arcus Challenges Merck in Kidney Cancer with Early Data

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, according to analysts at Truist Securities.

February 18, 2025
·
2 min read
·
Tristan Manalac

1 of 2,476

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin